Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Immunization of HIV-infected adult patients - French recommendations.

Frésard A, Gagneux-Brunon A, Lucht F, Botelho-Nevers E, Launay O.

Hum Vaccin Immunother. 2016 Nov;12(11):2729-2741. Epub 2016 Jul 13. Review.

2.

Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine.

Seo YB, Lee J, Song JY, Choi HJ, Cheong HJ, Kim WJ.

Hum Vaccin Immunother. 2016;12(2):478-84. doi: 10.1080/21645515.2015.1076599.

3.

Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants.

Nunes MC, Cutland CL, Dighero B, Bate J, Jones S, Hugo A, van Niekerk N, Kuwanda L, Izu A, Weinberg A, Madhi SA; Matflu Team.

J Infect Dis. 2015 Dec 15;212(12):1976-87. doi: 10.1093/infdis/jiv339. Epub 2015 Jun 16.

4.

Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.

Jambo KC, Banda DH, Afran L, Kankwatira AM, Malamba RD, Allain TJ, Gordon SB, Heyderman RS, Russell DG, Mwandumba HC.

Am J Respir Crit Care Med. 2014 Oct 15;190(8):938-47. doi: 10.1164/rccm.201405-0864OC.

5.

Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells.

Ramirez LA, Daniel A, Frank I, Tebas P, Boyer JD.

J Infect Dis. 2014 Aug 15;210(4):646-50. doi: 10.1093/infdis/jiu132. Epub 2014 Mar 8.

6.

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, Mofenson LM, Nesheim S; Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics.

Pediatr Infect Dis J. 2013 Nov;32 Suppl 2:i-KK4. doi: 10.1097/01.inf.0000437856.09540.11. No abstract available.

7.

Influenza vaccination in HIV-positive subjects: latest evidence and future perspective.

Ceravolo A, Orsi A, Parodi V, Ansaldi F.

J Prev Med Hyg. 2013 Mar;54(1):1-10. Review.

8.

Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011.

Cohen C, Moyes J, Tempia S, Groom M, Walaza S, Pretorius M, Dawood H, Chhagan M, Haffejee S, Variava E, Kahn K, Tshangela A, von Gottberg A, Wolter N, Cohen AL, Kgokong B, Venter M, Madhi SA.

Emerg Infect Dis. 2013 Nov;19(11):1766-74. doi: 10.3201/eid1911.130546.

9.

Rituximab-treated patients have a poor response to influenza vaccination.

Eisenberg RA, Jawad AF, Boyer J, Maurer K, McDonald K, Prak ET, Sullivan KE.

J Clin Immunol. 2013 Feb;33(2):388-96. doi: 10.1007/s10875-012-9813-x. Epub 2012 Oct 14.

10.

Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America.

Cohen C, Simonsen L, Sample J, Kang JW, Miller M, Madhi SA, Campsmith M, Viboud C.

Clin Infect Dis. 2012 Oct;55(7):996-1003. doi: 10.1093/cid/cis549. Epub 2012 Jun 19.

11.

The population-based burden of influenza-associated hospitalization in rural western Kenya, 2007-2009.

Feikin DR, Ope MO, Aura B, Fuller JA, Gikunju S, Vulule J, Ng'ang'a Z, Njenga MK, Breiman RF, Katz M.

Bull World Health Organ. 2012 Apr 1;90(4):256-263A. doi: 10.2471/BLT.11.094326.

12.

Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.

El Sahly HM, Davis C, Kotloff K, Meier J, Winokur PL, Wald A, Johnston C, George SL, Brady RC, Lehmann C, Stokes-Riner A, Keitel WA.

J Infect Dis. 2012 Mar 1;205(5):703-12. doi: 10.1093/infdis/jir837. Epub 2012 Jan 24.

13.

Risk factors for hospitalized seasonal influenza in rural western Kenya.

Ope MO, Katz MA, Aura B, Gikunju S, Njenga MK, Ng'ang'a Z, Vulule J, Breiman RF, Feikin DR.

PLoS One. 2011;6(5):e20111. doi: 10.1371/journal.pone.0020111. Epub 2011 May 26.

14.

Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.

Launay O, Desaint C, Durier C, Loulergue P, Duval X, Jacomet C, Pialoux G, Ghosn J, Raffi F, Rey D, Ajana F, Colin de Verdière N, Reynes J, Foubert V, Roman F, Devaster JM, Delfraissy JF, Aboulker JP; ANRS 151 HIFLUVAC Study Group and the French Clinical Vaccinology Network (Réseau National d'Investigation Clinique en Vaccinologie REIVAC).

J Infect Dis. 2011 Jul 1;204(1):124-34. doi: 10.1093/infdis/jir211.

15.

Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.

Althoff KN, Eichelberger M, Gange SJ, Sharp GB, Gao J, Glesby MJ, Young M, Greenblatt RM, French AL, Villacres MC, Minkoff H.

AIDS. 2011 Jun 1;25(9):1229-32. doi: 10.1097/QAD.0b013e3283471cf2.

16.

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.

Soonawala D, Rimmelzwaan GF, Gelinck LB, Visser LG, Kroon FP.

PLoS One. 2011 Jan 31;6(1):e16496. doi: 10.1371/journal.pone.0016496.

17.

Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Sheth AN, Althoff KN, Brooks JT.

Clin Infect Dis. 2011 Jan 15;52(2):219-27. doi: 10.1093/cid/ciq110. Review.

18.

Pneumonia and influenza hospitalization in HIV-positive seniors.

Mor SM, Aminawung JA, Demaria A Jr, Naumova EN.

Epidemiol Infect. 2011 Sep;139(9):1317-25. doi: 10.1017/S0950268810002669. Epub 2010 Nov 26.

19.

Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.

Althoff KN, Anastos K, Nelson KE, Celentano DD, Sharp GB, Greenblatt RM, French AL, Diamond DJ, Holman S, Young M, Gange SJ.

Prev Med. 2010 May-Jun;50(5-6):223-9. doi: 10.1016/j.ypmed.2010.03.007. Epub 2010 Mar 18.

20.

Influenza vaccines: from surveillance through production to protection.

Tosh PK, Jacobson RM, Poland GA.

Mayo Clin Proc. 2010 Mar;85(3):257-73. doi: 10.4065/mcp.2009.0615. Epub 2010 Jan 29. Review.

Supplemental Content

Support Center